Posts with or without credits tagged 'nvsq124'

For #Investors: CEO @VasNarasimhan joined @carlquintanilla on @moneymoverscnbc to discuss strong Q1 #Earnings, driven from: ➡️ Product portfolio, new launches and growth drivers ➡️ Confidence in innovative medicines ➡️ Continued pipeline momentum $NVS $NOVN #NVSQ124

CEO @VasNarasimhan discusses strong Q1 #Earnings on @BloombergTV: ➡️ Confidence in outlook. Raises FY guidance ➡️ Performance in key brands across US, Europe, Japan & China ➡️ Scaling innovative medicines, incl. for cancer using advanced therapies $NVS $NOVN #NVSQ124 #investors t.co/i6L8Ge

For #Investors: Novartis is prioritizing an emerging technology platform called #RadioligandTherapy (RLT), with continued investment into new R&D capabilities and manufacturing scale. $NVS $NOVN #NVSQ124

Q1 Earnings: A strong start to the year with continued momentum in our business and pipeline. Performance across all key growth brands and geographies gives continued confidence in our mid- and long-term growth. Guidance raised for full year 2024. $NVS $NOVN #NVSQ124

#NVSQ124 Novartis tweets on Q1 2024 results contain forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: t.co/bGtaZnhTn6 $NVS $NOVN